In summary, with IL-17 as a widely discussed inflammatory target, an increasing body of research supports its crucial role in mediating immune regulation through neuroinflammation and the microbiota–gut–brain axis in common neurological diseases and mental disorders. This evidence concerns the gene IL17A and psychiatric disorder.